A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Clinical trial NCT03628677 · COMPLETED
Trial details
- NCT number
- NCT03628677
- Sponsor
- Arcus Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2025-01-23
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.